Sign Up

    BLFE

    COM:BIOLIFESCIENCES

    BioLife Sciences

    • Stock

    USD

    Last Close

    0.00

    17/04 20:00

    Market Cap

    118

    Beta: -

    Volume Today

    50

    Avg: -

    OverviewMetricsFinancialsAPI
    Income StatementBalance SheetCash FlowKey MetricsRatios
    Quarterly
    Yearly

    Preview

    Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

    Subscribe NowHelp
    Nov '19
    Nov '20
    Nov '21
    Nov '22
    average inventory
    average payables
    246.34K
    -
    246.34K
    0%
    average receivables
    book value per share
    -0.00
    -
    -0.01
    22,346.81%
    capex per share
    -0.00
    -
    capex to depreciation
    capex to operating cash flow
    0.00
    -
    capex to revenue
    -0.00
    -
    cash per share
    0.00
    -
    0.00
    76,663.51%
    days of inventory on hand
    days payables outstanding
    128.80
    -
    days sales outstanding
    debt to assets
    2.61
    -
    debt to equity
    -0.27
    -
    dividend yield
    earnings yield
    -0.00
    -
    -0.02
    6,849.50%
    enterprise value
    3.64M
    -
    58.66M
    1,512.92%
    enterprise value over ebitda
    -47.17
    -
    ev to operating cash flow
    213.95K
    -
    -66.34
    100.03%
    ev to sales
    142.49
    -
    free cash flow per share
    0.00
    -
    -0.02
    1,956,241.62%
    free cash flow yield
    0.00
    -
    -0.02
    323,815.47%
    graham net net
    -0.00
    -
    -0.01
    23,583.05%
    graham number
    0.00
    -
    0.09
    30,602.42%
    income quality
    -0.01
    -
    0.70
    4,753.05%
    intangibles to total assets
    0
    -
    0
    0
    0
    interest coverage
    -25.21
    -
    interest debt per share
    0.00
    -
    inventory turnover
    invested capital
    -0.27
    -
    market cap
    3.64M
    -
    58.51M
    1,508.65%
    net current asset value
    -1.15K
    -
    -690.57K
    59,741.77%
    net debt to ebitda
    -0.12
    -
    net income per share
    -0.00
    -
    -0.02
    41,894.31%
    operating cash flow per share
    0.00
    -
    -0.02
    1,954,118.14%
    payables turnover
    2.83
    -
    receivables turnover
    research and ddevelopement to revenue
    return on tangible assets
    -66.71
    -
    -17.43
    73.86%
    revenue per share
    0.01
    -
    roe
    0.98
    -
    1.84
    87.08%
    roic
    2.49
    -
    sales general and administrative to revenue
    shareholders equity per share
    -0.00
    -
    -0.01
    22,346.81%
    stock based compensation to revenue
    tangible asset value
    -1.15K
    -
    -689.58K
    59,655.89%
    tangible book value per share
    -0.00
    -
    -0.01
    22,346.81%
    working capital
    -1.15K
    -
    -690.57K
    59,741.77%

    All numbers in USD (except ratios and percentages)